Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Gynecologic 1

Conditions

Glioblastoma 3Lymphoma, Follicular 1Endometrial Neoplasms 1Breast Neoplasms 1

Interventions

Paclitaxel 34Carboplatin 27pembrolizumab 20Bevacizumab 16Letrozole 13Megestrol Acetate 10Cisplatin 9lenvatinib 8olaparib 7dostarlimab 7Metformin 7durvalumab 6abemaciclib 6Radiotherapy 6Everolimus 6niraparib 5Specimen Handling 5Nivolumab 5Medroxyprogesterone Acetate 5Magnetic Resonance Spectroscopy 5Gemcitabine 5Fluorouracil 5Docetaxel 5Biopsy 5temsirolimus 4rucaparib 4Oxaliplatin 4Fulvestrant 4Doxorubicin 4sapanisertib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Endometrial Neoplasms × Diet, Ketogenic × Clear all
NCT04750941 2025-03-04

Study of Copanlisib and Ketogenic Diet

Columbia University

Phase 2 Terminated
1 enrolled 9 charts
GynecologicLymphoid

Lymphoma, Follicular, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡